Sawhney Roger has filed 3 insider transactions across 2 companies since August 2024.
Most recent transaction: a grant/award of 157600 shares of Arbutus Biopharma Corp ($ABUS) on August 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 4, 2025 | Arbutus Biopharma Corp | $ABUS | Sawhney Roger | Director | A | Stock Option (Right to Buy) | 157600 | $0.00 | 157,600.0000 | 191,480,188 | 9999.99% | 0.08% |
| May 22, 2025 | ACTUATE THERAPEUTICS, INC. | $ACTU | Sawhney Roger | Director | A | Stock Options | 15000 | $0.00 | 15,000.0000 | 19,531,636 | 9999.99% | 0.08% |
| Aug. 12, 2024 | ACTUATE THERAPEUTICS, INC. | $ACTU | Sawhney Roger | Director | A | Non-Qualified Stock Options | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |